Inflammation, proteases and cancer.
Tumours are complex tissues composed of ever-evolving neoplastic cells, matrix proteins that provide structural support and sequester biologically active molecules, and a cellular stromal component. Reciprocal interactions between neoplastic cells, activated host cells and the dynamic micro-environment in which they live enables tumour growth and dissemination. It has become evident that early and persistent inflammatory responses observed in or around developing neoplasms regulates many aspects of tumour development (matrix remodelling, angiogenesis, malignant potential) by providing diverse mediators implicated in maintaining tissue homeostasis, e.g., soluble growth and survival factors, matrix remodelling enzymes, reactive oxygen species and other bioactive molecules. This review highlights recent insights into the role of chronic inflammation associated with cancer development and examines proteolytic pathways activated by infiltrating leukocytes during neoplastic programming of tissues.
van Kempen
Léon C L
LC
Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Geert Grooteplein 24, 6525 GA Nijmegen, The Netherlands.
de Visser
Karin E
KE
Coussens
Lisa M
LM
D016207:Cytokines / Q000502:physiology; D006801:Humans; D007111:Immunity, Cellular; D007249:Inflammation / Q000201:enzymology*; D007962:Leukocytes / Q000502:physiology; D009369:Neoplasms / Q000201:enzymology* / Q000276:immunology; D019899:Paracrine Communication / Q000502:physiology; D010447:Peptide Hydrolases / Q000502:physiology*
D016207:Cytokines; D010447:Peptide Hydrolases